Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Blue Bird Corp (NQ: BLBD ) 45.99 -0.11 (-0.24%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Blue Bird Corp < Previous 1 2 3 4 5 Next > Blue Bird Applauds EPA’s $965 Million Clean School Bus Funding to Accelerate Adoption of Zero-Emission Student Transportation October 01, 2024 From Blue Bird Corporation Via Business Wire Blue Bird Announces Resignation of President; Phil Horlock to Remain as President and CEO September 09, 2024 From Blue Bird Corporation Via Business Wire Blue Bird Delivers its 2,000th Electric School Bus August 27, 2024 From Blue Bird Corporation Via Business Wire Blue Bird Reports Fiscal 2024 Third Quarter Record Results; Raises 2024 Guidance and Long-Term Outlook August 07, 2024 From Blue Bird Corporation Via Business Wire Blue Bird Announces CEO and Chairman Transition Plan August 07, 2024 From Blue Bird Corporation Via Business Wire Blue Bird and Generate Capital Appoint General Manager for Clean Bus Solutions Joint Venture July 30, 2024 From Blue Bird Corporation and Generate Capital Via Business Wire Blue Bird to Report Fiscal 2024 Third Quarter Results on August 7, 2024 July 24, 2024 From Blue Bird Corporation Via Business Wire Blue Bird Selected to Receive $80 Million Federal Grant to Expand Electric Vehicle Manufacturing July 11, 2024 From Blue Bird Corporation Via Business Wire Glancy Prongay & Murray LLP Announces Investigation of Blue Bird Corporation (BLBD) (f/k/a Hennessy Capital Acquisition Corp.) June 28, 2024 From Glancy Prongay & Murray LLP Via Business Wire Blue Bird’s Gurminder Bedi Steps Down from Board of Directors After Long Tenure June 28, 2024 From Blue Bird Corporation Via Business Wire Blue Bird Launches Most Comprehensive School Bus Safety Upgrades in its History June 13, 2024 From Blue Bird Corporation Via Business Wire Blue Bird Announces Ratification of Collective Bargaining Agreement by United Steelworkers May 24, 2024 From Blue Bird Corporation Via Business Wire Blue Bird Debuts Electric Step Van at 2024 Advanced Clean Transportation (ACT) Expo May 20, 2024 From Blue Bird Corporation Via Business Wire Blue Bird Expands Leadership of Sales and Marketing Organization May 14, 2024 From Blue Bird Corporation Via Business Wire Blue Bird Reports Fiscal 2024 Second Quarter Record Results; Raises 2024 Guidance and Long-Term Outlook May 08, 2024 From Blue Bird Corporation Via Business Wire Blue Bird Extends Exclusive Clean School Bus Collaboration with Ford Component Sales and ROUSH CleanTech to 2030 May 01, 2024 From Blue Bird Corporation Via Business Wire Blue Bird to Report Fiscal 2024 Second Quarter Results on May 8, 2024 April 24, 2024 From Blue Bird Corporation Via Business Wire Blue Bird Corp. (NASDAQ: BLBD) Records 52-Week High Wednesday Morning April 03, 2024 Via Investor Brand Network Topics Energy Exposures Fossil Fuels Blue Bird Corp. (NASDAQ: BLBD) Records 52-Week High Thursday Morning March 28, 2024 Via Investor Brand Network Topics Energy Exposures Fossil Fuels Blue Bird Corp. (NASDAQ: BLBD) Sets New 52-Week High in Friday Session March 01, 2024 Via Investor Brand Network Topics Energy Exposures Fossil Fuels Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise February 27, 2024 Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - February 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining... Via Newsfile Is CRISPR Therapeutics the NVIDIA of gene editing? February 26, 2024 CRISPR Therapeutics AG (NASDAQ: CRSP) made worldwide headlines when it and partner Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) received the first-ever FDA approv Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety Blue Bird Announces Launch of Secondary Public Offering February 15, 2024 From Blue Bird Corporation Via Business Wire Gene therapy: Why does it cost millions for a single treatment? February 15, 2024 Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology. Via MarketBeat Exposures Product Safety Blue Bird Corp. (NASDAQ: BLBD) Records 52-Week High Thursday Morning February 08, 2024 Via Investor Brand Network Topics Energy Exposures Fossil Fuels Blue Bird Reports Fiscal 2024 First Quarter Record Results; Raises 2024 Guidance February 07, 2024 From Blue Bird Corporation Via Business Wire Glancy Prongay & Murray LLP Announces Investigation of Blue Bird Corporation (BLBD) (f/k/a Hennessy Capital Acquisition Corp.) February 02, 2024 From Glancy Prongay & Murray LLP Via Business Wire Blue Bird Announces Authorization of $60 Million Stock Repurchase Program February 01, 2024 From Blue Bird Corporation Via Business Wire Blue Bird to Report Fiscal 2024 First Quarter Results on February 7, 2024 January 24, 2024 From Blue Bird Corporation Via Business Wire Blue Bird Receives Record Order of 180 Electric School Buses January 16, 2024 From Blue Bird Corporation Via Business Wire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.